表紙
市場調査レポート

世界の次世代型シーケンシング市場

Global Next-generation Sequencing Market

発行 Frost & Sullivan 商品コード 306532
出版日 ページ情報 英文 139 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
世界の次世代型シーケンシング市場 Global Next-generation Sequencing Market
出版日: 2014年06月20日 ページ情報: 英文 139 Pages
概要

当レポートでは、全世界の次世代型シーケンシング−−従来型のキャピラリー電気泳動(CE)法に代わる各種シーケンシング解析装置・試薬−−市場について分析し、市場の促進・阻害要因や、地域別・製品別の市場動向の見通し、今後の市場成長への主な影響要因、主要企業の概略、潜在的な参入企業に対して今後取るべき手段などの情報をお届けします。

当レポートは、以下の疑問にお答えいたします。

  • 米国政府の強制予算削減(国立研究機関等を含む)は市場にどのような影響を与えたのか?
  • 次世代型シーケンシングの導入促進要因とは何か?
  • 新規参入企業は今後の強敵となるのか?その理由は?
  • 市場構造は今後どう変化するのか?企業買収に適した状態となるのか?
  • 新たな成長機会をもたらすのはどの顧客ベースか?
  • 次世代型シーケンシングの臨床現場への導入は、市場にどのような影響をもたらすのか?

第1章 エグゼクティブ・サマリー

第2章 市場概況

  • 市場の背景
  • 市場の分類
  • 世界市場の展望
  • 今後の医療動向の定義

第3章 競争戦略

  • 新たな市場機会
  • 企業合併・買収(M&A)および事業提携契約

第4章 市場の促進・抑制要因および動向

  • 市場促進要因
  • 市場抑制要因
  • 市場の主な動向とその影響度

第5章 市場の予測と傾向

  • 市場計測
  • 予測の前提条件と手法
  • 市場収益額の予測:市場全体
  • 市場収益額の予測:製品の種類別
  • 市場収益額の予測:製品別シェア
  • 市場収益額の予測:地域別
  • 市場収益額の予測:地域別シェア
  • 調達プロセス

第6章 競争環境

  • 解析装置市場の競争環境
  • 解析装置の分析:用途への適合性
    • Illumina
    • Life Technologies
    • Roche
    • Pacific Biosciences
  • 解析装置:次世代シーケンシング(NGS)プラットフォーム関連の取引動向
  • 解析装置市場:今後の新規参入企業
  • 解析装置市場:SWOT分析
  • 試薬市場の競争環境
  • 試薬製品の分析
  • 試薬製品の傾向

第7章 次世代型シーケンシング装置市場の詳細分析

  • 主な分析結果
  • 市場計測
  • 市場収益額
  • 市場シェア分析

第8章 次世代型シーケンシング用試薬市場の詳細分析

第9章 米国市場の詳細分析

  • 市場計測
  • 米国市場の分析
  • 市場収益額の予測
  • 市場収益額の予測:製品の種類別

第10章 西欧市場の詳細分析

第11章 アジア太平洋地域および他の国々(ROW)の市場の詳細分析

第12章 結論

  • 3つの主な予測
  • 人口規模の分析
  • ゲノムの臨床的有用性向上のためのデータベース構築
  • 法的免責事項

第13章 付録

目次
Product Code: NE1A-52

On the Verge of a Quadrupled Competitor Size and a Clinical Turning Point

The total market, as defined by this study, includes next-generation sequencing instruments and reagents. Instruments include those that use newer technology than traditional capillary electrophoresis (CE) sequencing, such as sequencing-by-synthesis, sequencing-by-ligation, single-molecule sequencing, and semiconductor sequencing. This research service offers a discussion of the key market drivers and restraints, revenue forecasts by region (United States, Western Europe, and Asia-Pacific/Rest of World) and product types, as well as important trends affecting growth. This analysis also presents key companies to watch, major market dynamics, and strategic recommendations for competitors.

Key Questions This Study Will Answer

  • What impact did US sequestration measures for federally funded government and academic laboratories have on the market?
  • What application trends are driving adoption of next-generation sequencing?
  • Which emerging or anticipated companies should be on competitors' radar, and why?
  • How will the structure of the market change over time? Is it ripe for acquisitions?
  • What customer bases offer new opportunities for growth?
  • How will the adoption of next-generation sequencing for clinical applications affect the market?

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Scope and Segmentation
  • 4. Key Questions This Study Will Answer
  • 5. Measurements
  • 6. CEO's Perspective
  • 7. Key Companies to Watch
  • 8. Key Companies to Watch (continued)
  • 9. Key Companies to Watch (continued)
  • 10. Executive Summary-3 Big Predictions

2. MARKET OVERVIEW

  • 1. Market Background
  • 2. Market Segmentation
  • 3. Global Market Perspective
  • 4. Defining Healthcare Trends in the Future

3. COMPETITIVE PLAYBOOK

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)
  • 3. New Market Opportunities (continued)
  • 4. New Market Opportunities (continued)
  • 5. New Market Opportunities (continued)
  • 6. Merger, Acquisition, and Partnership Assessment
  • 7. Merger, Acquisition, and Partnership Assessment (continued)
  • 8. Merger, Acquisition, and Partnership Assessment (continued)

4. DRIVERS, RESTRAINTS, AND TRENDS-TOTAL NEXT-GENERATION SEQUENCING MARKET

  • 1. Market Drivers
  • 2. Market Restraints
  • 3. Market Impact of Top Trends

5. FORECASTS AND TRENDS-TOTAL NEXT-GENERATION SEQUENCING MARKET

  • 1. Measurements
  • 2. Forecast Assumptions and Methodology
  • 3. Total Next-generation Sequencing Market-Revenue Forecast
  • 4. Total Next-generation Sequencing Market-Revenue Forecast by Product Type
  • 5. Total Next-generation Sequencing Market-Revenue Forecast by Product Type (continued)
  • 6. Total Next-generation Sequencing Market-Percent Revenue Forecast by Product Type
  • 7. Total Next-generation Sequencing Market-Revenue Forecast by Region
  • 8. Total Next-generation Sequencing Market-Revenue Forecast by Region (continued)
  • 9. Total Next-generation Sequencing Market-Percent Revenue Forecast by Region
  • 10. Revenue Forecast Discussion
  • 11. Revenue Forecast Discussion (continued)
  • 12. Procurement Process

6. COMPETITIVE ENVIRONMENT

  • 1. Competitive Environment-Instruments
  • 2. Instruments Product Analysis-Illumina
  • 3. Instruments Product Analysis-Illumina (continued)
  • 4. Instruments Product Analysis-Illumina (continued)
  • 5. Instruments Product Analysis-Illumina (continued)
  • 6. Instruments Product Analysis-Illumina (continued)
  • 7. Illumina-Application Suitability
  • 8. Instruments Product Analysis-Life Technologies
  • 9. Instruments Product Analysis-Life Technologies (continued)
  • 10. Instruments Product Analysis-Life Technologies (continued)
  • 11. Life Technologies-Application Suitability
  • 12. Instruments Product Analysis-Roche
  • 13. Instruments Product Analysis-Roche (continued)
  • 14. Instruments Product Analysis-Roche (continued)
  • 15. Roche/454-Application Suitability
  • 16. Instruments Product Analysis-Pacific Biosciences
  • 17. Instruments Product Analysis-Pacific Biosciences (continued)
  • 18. Instruments Product Analysis-Pacific Biosciences (continued)
  • 19. Pacific Biosciences-Application Suitability
  • 20. NGS Platform Trending-Instruments
  • 21. Future Competitors-Instruments
  • 22. SWOT Analysis-Instruments
  • 23. SWOT Analysis-Instruments (continued)
  • 24. SWOT Analysis-Instruments (continued)
  • 25. Competitive Environment-Reagents
  • 26. Reagents Product Analysis
  • 27. Reagents Product Analysis (continued)
  • 28. Reagents Product Analysis (continued)
  • 29. Reagents Product Analysis (continued)
  • 30. Reagents Product Trends

7. NEXT-GENERATION SEQUENCING INSTRUMENTS MARKET BREAKDOWN

  • 1. Next-generation Sequencing Instruments Market-Key Findings
  • 2. Measurements
  • 3. Next-generation Sequencing Instruments Market-Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Next-generation Sequencing Instruments Market-Market Share Analysis

8. NEXT-GENERATION SEQUENCING REAGENTS MARKET BREAKDOWN

  • 1. Next-generation Sequencing Reagents Market-Key Findings
  • 2. Measurements
  • 3. Next-generation Sequencing Reagents Market-Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Next-generation Sequencing Reagents Market-Percent Revenue Forecast by Usage

9. US NEXT-GENERATION SEQUENCING MARKET BREAKDOWN

  • 1. Measurements
  • 2. US Market Analysis
  • 3. US Next-generation Sequencing Market-Revenue Forecast
  • 4. US Next-generation Sequencing Market-Revenue Forecast by Product Type
  • 5. Revenue Forecast Discussion
  • 6. Revenue Forecast Discussion (continued)

10. WESTERN EUROPE NEXT-GENERATION SEQUENCING MARKET BREAKDOWN

  • 1. Measurements
  • 2. Western Europe Market Analysis
  • 3. Western Europe Next-generation Sequencing Market-Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Revenue Forecast Discussion (continued)
  • 6. Western Europe Next-generation Sequencing Market-Revenue Forecast by Product Type

11. ASIA-PACIFIC AND REST OF WORLD NEXT-GENERATION SEQUENCING MARKET BREAKDOWN

  • 1. Measurements
  • 2. APAC/ROW Market Analysis
  • 3. APAC/ROW Next-generation Sequencing Market-Revenue Forecast
  • 4. APAC/ROW Next-generation Sequencing Market-Revenue Forecast by Product Type
  • 5. Revenue Forecast Discussion
  • 6. Revenue Forecast Discussion (continued)

12. THE LAST WORD

  • 1. The Last Word-Three Big Predictions
  • 2. The Last Word-Population-sized Studies
  • 3. The Last Word-Creation of Databases to Increase the Clinical Utility of the Genome
  • 4. The Last Word-Creation of Databases to Increase the Clinical Utility of the Genome (continued)
  • 5. The Last Word-Population-sized Studies
  • 6. The Last Word-Population-sized Studies (continued)
  • 7. Legal Disclaimer

13. APPENDIX

  • 1. Drivers Explained
  • 2. Drivers Explained (continued)
  • 3. Drivers Explained (continued)
  • 4. Drivers Explained (continued)
  • 5. Drivers Explained (continued)
  • 6. Drivers Explained (continued)
  • 7. Drivers Explained (continued)
  • 8. Drivers Explained (continued)
  • 9. Restraints Explained
  • 10. Restraints Explained (continued)
  • 11. Restraints Explained (continued)
  • 12. Restraints Explained (continued)
  • 13. Restraints Explained (continued)
  • 14. Additional Sources of Information
  • 15. Methodology
  • 16. Learn More-Next Steps
Back to Top